These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1550 related items for PubMed ID: 29852056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pulp treatment for extensive decay in primary teeth.
    Smaïl-Faugeron V, Courson F, Durieux P, Muller-Bolla M, Glenny AM, Fron Chabouis H.
    Cochrane Database Syst Rev; 2014 Aug 06; (8):CD003220. PubMed ID: 25099759
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. No clear evidence of superiority regarding pulp medicaments in primary molars.
    Elkhadem A, Sami I.
    Evid Based Dent; 2014 Dec 06; 15(4):100-1. PubMed ID: 25522937
    [Abstract] [Full Text] [Related]

  • 5. Pulp treatment for extensive decay in primary teeth.
    Nadin G, Goel BR, Yeung CA, Glenny AM.
    Cochrane Database Syst Rev; 2003 Dec 06; (1):CD003220. PubMed ID: 12535462
    [Abstract] [Full Text] [Related]

  • 6. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B, Sigal M, Clokie C, Rukavina J, Titley K, Kulkarni GV.
    Int J Paediatr Dent; 2005 Nov 06; 15(6):437-47. PubMed ID: 16238654
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.
    Eidelman E, Holan G, Fuks AB.
    Pediatr Dent; 2001 Nov 06; 23(1):15-8. PubMed ID: 11242724
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D, Jayanthi M.
    Indian J Dent Res; 2011 Nov 06; 22(3):385-90. PubMed ID: 22048576
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.
    Ng FK, Messer LB.
    Eur Arch Paediatr Dent; 2008 Jun 06; 9(2):58-73. PubMed ID: 18534173
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of formocresol and mineral trioxide aggregate in pulpotomized primary molars--2 year follow up.
    Airen P, Shigli A, Airen B.
    J Clin Pediatr Dent; 2012 Jun 06; 37(2):143-7. PubMed ID: 23534319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 78.